ClinicalTrials.govpublic full text
Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma
multiple myeloma, relapsed multiple myeloma, antibody drug conjugate, refractory multiple myeloma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 892650
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.